289
Neoadjuvant chemotherapy reduces operative morbidity without effecting time to recurrence in advanced stage epithelial ovarian cancer
Neoadjuvant chemotherapy reduces operative morbidity without effecting time to recurrence in advanced stage epithelial ovarian cancer
Saturday, March 28, 2015: 9:55 AM
Salon C-D (Hilton Chicago)